Application of human umbilical cord blood-derived mesenchymal stem cells in disease models
- 1 January 2010
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Stem Cells
- Vol. 2 (2), 34-38
- https://doi.org/10.4252/wjsc.v2.i2.34
Abstract
Human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs) are regarded as an alternative source of bone marrow-derived mesenchymal stem cells because collection of cord blood is less invasive than that of bone marrow. hUCB-MSCs have recently been studied for evaluation of their potential as a source of cell therapy. In this review, the general characteristics of hUCB-MSCs and their therapeutic effects on various diseases in vitro and in vivo will be discussed.Keywords
This publication has 33 references indexed in Scilit:
- Human Umbilical Cord Blood-derived Stromal Cells Suppress Xenogeneic Immune Cell Response In VitroCroatian Medical Journal, 2009
- Umbilical Cord Blood‐Derived Stem Cells and Brain RepairAnnals of the New York Academy of Sciences, 2005
- Human Bone Marrow–Derived Mesenchymal Stem Cells in the Treatment of GliomasCancer Research, 2005
- Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsivenessBlood, 2005
- Thrombospondin 2 Functions as an Endogenous Regulator of Angiogenesis and Inflammation in Rheumatoid ArthritisThe American Journal of Pathology, 2004
- Skeletal Myogenic Differentiation of Mesenchymal Stem Cells Isolated from Human Umbilical Cord BloodThe International Journal of Cell Cloning, 2004
- HLA expression and immunologic propertiesof differentiated and undifferentiated mesenchymal stem cellsExperimental Hematology, 2003
- Graft-versus-host disease: emerging concepts in prevention and therapy.2003
- Pluripotency of mesenchymal stem cells derived from adult marrowNature, 2002
- Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivoExperimental Hematology, 2002